Literature DB >> 22223855

Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke.

S W Worm1, D A Kamara, P Reiss, E Fontas, S De Wit, W El-Sadr, A D'Arminio Monforte, M Law, A Phillips, L Ryom, F Dabis, R Weber, C Sabin, J D Lundgren.   

Abstract

Concerns have arisen about possible effects of protease inhibitors (PIs) on cardiac conductivity. We found no significant association between current or recent PI exposure and sudden death or nonhemorrhagic stroke (adjusted rate ratio, 1.22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11).

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22223855     DOI： 10.1093/infdis/jir788

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  12 in total

1.  PR Interval and sudden cardiac death in patients with HIV infection.

Authors:  Zian H Tseng; Brian Moyers; Eric A Secemsky; Diane V Havlir; Priscilla Y Hsue
Journal:  J Infect Dis       Date:  2012-11-27       Impact factor: 5.226

2.  HIV protease inhibitor exposure predicts cerebral small vessel disease.

Authors:  Virawudh Soontornniyomkij; Anya Umlauf; Sandra A Chung; Megan L Cochran; Benchawanna Soontornniyomkij; Ben Gouaux; Will Toperoff; David J Moore; Eliezer Masliah; Ronald J Ellis; Igor Grant; Cristian L Achim
Journal:  AIDS       Date:  2014-06-01       Impact factor: 4.177

3.  Relationship Between HIV Infection, Antiretroviral Therapy, Inflammatory Markers, and Cerebrovascular Endothelial Function Among Adults in Urban China.

Authors:  Felicia C Chow; Yanling Li; Yinghuan Hu; Joy Chan; Huanling Wang; Weihai Xu; Richard W Price; Farzaneh A Sorond; Taisheng Li
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

Review 4.  Neurologic Complications in Treated HIV-1 Infection.

Authors:  Nisha S Bhatia; Felicia C Chow
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

5.  Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy.

Authors:  Wanwarang Wongcharoen; Kolakrit Khienprasit; Arintaya Phrommintikul; Apichard Sukonthasarn; Nipon Chattipakorn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-06-09       Impact factor: 1.468

6.  HIV stroke risk: evidence and implications.

Authors:  Elyse J Singer; Miguel Valdes-Sueiras; Deborah L Commins; William Yong; Margrit Carlson
Journal:  Ther Adv Chronic Dis       Date:  2013-03       Impact factor: 5.091

7.  Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Authors:  Jeffrey L Lennox; Raphael J Landovitz; Heather J Ribaudo; Ighovwerha Ofotokun; Lumine H Na; Catherine Godfrey; Daniel R Kuritzkes; Manish Sagar; Todd T Brown; Susan E Cohn; Grace A McComsey; Francesca Aweeka; Carl J Fichtenbaum; Rachel M Presti; Susan L Koletar; David W Haas; Kristine B Patterson; Constance A Benson; Bryan P Baugh; Randi Y Leavitt; James F Rooney; Daniel Seekins; Judith S Currier
Journal:  Ann Intern Med       Date:  2014-10-07       Impact factor: 25.391

Review 8.  Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?

Authors:  Chris T Longenecker; Virginia A Triant
Journal:  Curr Opin HIV AIDS       Date:  2014-01       Impact factor: 4.283

9.  Magnetic Resonance Imaging of Cerebral Small Vessel Disease in Men Living with HIV and HIV-Negative Men Aged 50 and Above.

Authors:  Lewis J Haddow; Carole H Sudre; Magdalena Sokolska; Richard C Gilson; Ian G Williams; Xavier Golay; Sebastien Ourselin; Alan Winston; Caroline A Sabin; M Jorge Cardoso; H Rolf Jäger
Journal:  AIDS Res Hum Retroviruses       Date:  2019-02-20       Impact factor: 2.205

10.  In vivo assessment of antiretroviral therapy-associated side effects.

Authors:  Eduardo Milton Ramos-Sanchez; Hiro Goto; Dolores Helena Rodriguez Ferreira Rivero; Thais Mauad; Fernando Nogueira de Souza; Andrea Moreira Monteiro; Magnus Gidlund
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-07       Impact factor: 2.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.